A detailed history of Willis Investment Counsel transactions in Johnson & Johnson stock. As of the latest transaction made, Willis Investment Counsel holds 308,029 shares of JNJ stock, worth $49.7 Million. This represents 3.19% of its overall portfolio holdings.

Number of Shares
308,029
Previous 295,737 4.16%
Holding current value
$49.7 Million
Previous $46.8 Million 3.76%
% of portfolio
3.19%
Previous 3.25%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

BUY
$144.38 - $157.78 $1.77 Million - $1.94 Million
12,292 Added 4.16%
308,029 $45 Million
Q1 2024

Apr 24, 2024

BUY
$155.22 - $162.74 $15,211 - $15,948
98 Added 0.03%
295,737 $46.8 Million
Q4 2023

Jan 11, 2024

BUY
$145.6 - $158.88 $43,388 - $47,346
298 Added 0.1%
295,639 $46.3 Million
Q3 2023

Mar 07, 2024

SELL
$155.75 - $174.48 $5.7 Million - $6.38 Million
-36,585 Reduced 11.02%
295,341 $46 Million
Q3 2023

Oct 17, 2023

SELL
$155.75 - $174.48 $5.7 Million - $6.38 Million
-36,585 Reduced 11.02%
295,341 $46 Million
Q2 2023

Mar 07, 2024

BUY
$154.35 - $166.11 $76,711 - $82,556
497 Added 0.15%
331,926 $54.9 Million
Q2 2023

Jul 11, 2023

BUY
$154.35 - $166.11 $76,711 - $82,556
497 Added 0.15%
331,926 $54.9 Million
Q1 2023

Mar 07, 2024

BUY
$151.05 - $180.26 $5.41 Million - $6.45 Million
35,790 Added 12.11%
331,429 $51.4 Million
Q1 2023

Apr 18, 2023

BUY
$151.05 - $180.26 $384,422 - $458,761
2,545 Added 0.77%
331,429 $51.4 Million
Q4 2022

Jan 18, 2023

BUY
$160.2 - $179.79 $217,551 - $244,154
1,358 Added 0.41%
328,884 $0
Q3 2022

Oct 12, 2022

SELL
$161.33 - $179.52 $4.26 Million - $4.73 Million
-26,375 Reduced 7.45%
327,526 $53.5 Million
Q2 2022

Aug 08, 2022

SELL
$168.19 - $186.01 $2.08 Million - $2.3 Million
-12,379 Reduced 3.38%
353,901 $62.8 Million
Q1 2022

May 16, 2022

BUY
$158.14 - $179.59 $82,707 - $93,925
523 Added 0.14%
366,280 $64.9 Million
Q4 2021

Feb 14, 2022

BUY
$155.93 - $173.01 $1.8 Million - $2 Million
11,553 Added 3.26%
365,757 $62.6 Million
Q3 2021

Nov 17, 2021

BUY
$161.5 - $179.47 $3.3 Million - $3.66 Million
20,415 Added 6.12%
354,204 $57.2 Million
Q2 2021

Aug 13, 2021

BUY
$159.48 - $171.07 $3.24 Million - $3.48 Million
20,335 Added 6.49%
333,789 $55 Million
Q1 2021

May 17, 2021

SELL
$153.07 - $170.48 $1.34 Million - $1.5 Million
-8,775 Reduced 2.72%
313,454 $51.5 Million
Q4 2020

Feb 11, 2021

BUY
$137.11 - $157.38 $10.6 Million - $12.2 Million
77,360 Added 31.59%
322,229 $50.7 Million
Q3 2020

Nov 12, 2020

SELL
$140.38 - $153.83 $1.55 Million - $1.7 Million
-11,035 Reduced 4.31%
244,869 $36.5 Million
Q2 2020

Aug 14, 2020

SELL
$128.81 - $155.51 $3.43 Million - $4.14 Million
-26,596 Reduced 9.41%
255,904 $36 Million
Q1 2020

May 13, 2020

SELL
$111.14 - $153.99 $2.01 Million - $2.78 Million
-18,065 Reduced 6.01%
282,500 $37 Million
Q4 2019

Feb 13, 2020

BUY
$127.5 - $146.44 $510,255 - $586,052
4,002 Added 1.35%
300,565 $43.8 Million
Q3 2019

Nov 15, 2019

BUY
$126.95 - $142.14 $3.24 Million - $3.62 Million
25,490 Added 9.4%
296,563 $38.4 Million
Q2 2019

Aug 14, 2019

BUY
$131.15 - $144.24 $8.44 Million - $9.28 Million
64,370 Added 31.14%
271,073 $37.8 Million
Q1 2019

May 14, 2019

SELL
$125.72 - $139.79 $4.39 Million - $4.88 Million
-34,915 Reduced 14.45%
206,703 $20.9 Million
Q4 2018

Feb 14, 2019

SELL
$122.84 - $147.84 $4.67 Million - $5.63 Million
-38,050 Reduced 13.61%
241,618 $31.2 Million
Q3 2018

Nov 15, 2018

BUY
$121.58 - $142.88 $1.79 Million - $2.1 Million
14,727 Added 5.56%
279,668 $38.6 Million
Q2 2018

Aug 14, 2018

BUY
$119.4 - $131.76 $235,576 - $259,962
1,973 Added 0.75%
264,941 $32.1 Million
Q1 2018

May 11, 2018

BUY
$125.1 - $148.14 $2.19 Million - $2.6 Million
17,520 Added 7.14%
262,968 $33.7 Million
Q4 2017

Feb 14, 2018

SELL
$131.22 - $143.62 $1.69 Million - $1.85 Million
-12,865 Reduced 4.98%
245,448 $34.3 Million
Q3 2017

Nov 13, 2017

BUY
$129.47 - $135.38 $33.4 Million - $35 Million
258,313
258,313 $33.6 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $422B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Willis Investment Counsel Portfolio

Follow Willis Investment Counsel and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Willis Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Willis Investment Counsel with notifications on news.